Jianmin Pharmaceutical Group Co.,Ltd. (SHA:600976)
China · Delayed Price · Currency is CNY 32.04
+0.32 (1.01%)
Apr 29, 2026, 3:00 PM CST
SHA:600976 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 337.4 | 359.84 | 362.18 | 521.46 | 408.08 | 305.26 |
Depreciation & Amortization | 45.05 | 45.05 | 41.18 | 40.33 | 38.82 | 34.12 |
Other Amortization | 26.78 | 26.78 | 29.4 | 18.73 | 15.86 | 15.92 |
Loss (Gain) From Sale of Assets | 0.15 | 0.15 | 0.12 | -0.68 | 0.02 | -0.48 |
Asset Writedown & Restructuring Costs | 0.68 | 0.68 | 2.96 | 11.91 | 10.73 | 1.5 |
Loss (Gain) From Sale of Investments | -137.48 | -137.48 | -254.49 | -243.27 | -153.59 | -123.21 |
Provision & Write-off of Bad Debts | 17.58 | 17.58 | 44.74 | 3.47 | 10.09 | 5.4 |
Other Operating Activities | 107.32 | 14.13 | 20.82 | 16.71 | 20.41 | 10.15 |
Change in Accounts Receivable | -40.58 | -40.58 | 140.3 | -252.67 | -302.98 | 3.99 |
Change in Inventory | 63.37 | 63.37 | 95.64 | -92.82 | -140.29 | 9.96 |
Change in Accounts Payable | -21.88 | -21.88 | -261.22 | 258.71 | 299.01 | 4.47 |
Change in Other Net Operating Assets | 0.12 | 0.12 | 2.44 | 8.85 | 9.44 | 10.27 |
Operating Cash Flow | 345.27 | 274.53 | 234.27 | 268.39 | 215.87 | 247.92 |
Operating Cash Flow Growth | 32.29% | 17.19% | -12.72% | 24.33% | -12.93% | 97.48% |
Capital Expenditures | -107.9 | -100.67 | -120.29 | -64.5 | -67.96 | -56.15 |
Sale of Property, Plant & Equipment | 0.45 | 0.38 | 0.39 | 2.88 | 0.24 | 1.15 |
Divestitures | - | - | - | 18.94 | - | - |
Investment in Securities | -43.47 | -47.37 | -127 | -137.82 | -75.47 | 62.38 |
Other Investing Activities | -86.3 | - | - | 103.19 | - | - |
Investing Cash Flow | -237.22 | -147.65 | -246.9 | -77.31 | -143.2 | 7.38 |
Short-Term Debt Issued | - | - | - | - | 103.5 | 45 |
Long-Term Debt Issued | - | 85.58 | 154.8 | 79.45 | 3.2 | 10.44 |
Total Debt Issued | 42.48 | 85.58 | 154.8 | 79.45 | 106.7 | 55.44 |
Short-Term Debt Repaid | - | - | - | - | -126 | -20 |
Long-Term Debt Repaid | - | -119.8 | -96.65 | -30.2 | -101.16 | -2.87 |
Total Debt Repaid | -114.01 | -119.8 | -96.65 | -30.2 | -227.16 | -22.87 |
Net Debt Issued (Repaid) | -71.53 | -34.22 | 58.15 | 49.24 | -120.46 | 32.57 |
Issuance of Common Stock | - | - | - | - | 104.68 | 14.76 |
Repurchase of Common Stock | - | - | - | - | - | -38.34 |
Common Dividends Paid | -140.69 | -141.3 | -187.72 | -156.2 | -124.01 | -58.61 |
Other Financing Activities | -2.85 | 5.78 | 29.02 | 21.26 | -49.65 | 9.01 |
Financing Cash Flow | -215.08 | -169.74 | -100.56 | -85.7 | -189.44 | -40.6 |
Net Cash Flow | -107.03 | -42.86 | -113.2 | 105.39 | -116.77 | 214.69 |
Free Cash Flow | 237.37 | 173.86 | 113.98 | 203.89 | 147.9 | 191.77 |
Free Cash Flow Growth | 73.02% | 52.54% | -44.10% | 37.85% | -22.88% | 139.84% |
Free Cash Flow Margin | 7.08% | 5.16% | 3.25% | 4.84% | 4.06% | 5.81% |
Free Cash Flow Per Share | 1.55 | 1.15 | 0.75 | 1.33 | 0.97 | 1.26 |
Cash Income Tax Paid | 219.3 | 212.09 | 202.29 | 278.4 | 255.07 | 227.7 |
Levered Free Cash Flow | 155.44 | 119.23 | 122.08 | 143.06 | -27.82 | 261.85 |
Unlevered Free Cash Flow | 163.3 | 127.47 | 130.17 | 145.37 | -24.82 | 267.29 |
Change in Working Capital | -52.22 | -52.22 | -12.64 | -100.28 | -134.56 | -0.74 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.